pharma · Rheumatoid arthritis · Completely Resected Stage IIB, IIC, and III Melanoma
Celltrion Healthcare Australia
Celltrion Healthcare Australia Pty Ltd
Celltrion Healthcare Australia is a pharma organization headquartered in Sydney, AU. Primary therapeutic focus areas include Rheumatoid arthritis, Completely Resected Stage IIB, IIC, and III Melanoma, Previously Untreate
Sydney, AU HQ
9 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Sydney, AU
- Employees
- 9
- Programs
- 10
- Drugs
- 44
- Patents
- 0
CT-P51 1.1
Phase 1 · other · Completely Resected Stage IIB, IIC, and III Melanoma
CT-P51 1.1 for Completely Resected Stage IIB, IIC, and III Melanoma is a Phase 1 program (other) at Celltrion Healthcare Australia Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code CT-P51 1.1
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Celltrion Healthcare Australia Pty Ltd
- Phase
- Phase 1
- Modality
- other
- Indication
- Completely Resected Stage IIB, IIC, and III Melanoma
- Status
- active
- Trials
- 1